Seres Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MCRB and other ETFs, options, and stocks.

About MCRB

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. 

CEO
Eric D. Shaff
CEOEric D. Shaff
Employees
233
Employees233
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
233
Employees233

MCRB Key Statistics

Market cap
122.14M
Market cap122.14M
Price-Earnings ratio
-0.86
Price-Earnings ratio-0.86
Dividend yield
Dividend yield
Average volume
3.12M
Average volume3.12M
High today
$0.7982
High today$0.7982
Low today
$0.7616
Low today$0.7616
Open price
$0.787
Open price$0.787
Volume
3.02M
Volume3.02M
52 Week high
$6.87
52 Week high$6.87
52 Week low
$0.7324
52 Week low$0.7324

MCRB News

Yahoo Finance 21h
Increases to Seres Therapeutics, Inc.'s CEO Compensation Might Cool off for now - Yahoo Finance

Key Insights Seres Therapeutics' Annual General Meeting to take place on 4th of April CEO Eric Shaff's total compensation includes salary of US$685.0k Total...

Increases to Seres Therapeutics, Inc.'s CEO Compensation Might Cool off for now - Yahoo Finance
Simply Wall St 6d
Benign Growth For Seres Therapeutics, Inc. Underpins Stock's 30% Plummet - Simply Wall St

Unfortunately for some shareholders, the Seres Therapeutics, Inc. ( ) share price has dived 30% in the last thirty days, prolonging recent pain. The recent drop...

Benign Growth For Seres Therapeutics, Inc. Underpins Stock's 30% Plummet - Simply Wall St

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
14.3%
Sell
14.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.